Risk stratification and prognosis prediction based on inflammation-related gene signature in lung squamous carcinoma.

The IRG signature was a predictor for patients with LUSC and might serve as a potential indicator of the efficacy of immunotherapy. The nomogram based on the IRG signature showed a relatively good predictive performance in survival.